(NASDAQ: MDWD) Mediwound's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.36%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.85%.
Mediwound's earnings in 2026 is -$20,179,000.On average, 8 Wall Street analysts forecast MDWD's earnings for 2026 to be -$28,860,926, with the lowest MDWD earnings forecast at -$34,287,116, and the highest MDWD earnings forecast at -$26,840,468. On average, 8 Wall Street analysts forecast MDWD's earnings for 2027 to be -$28,948,716, with the lowest MDWD earnings forecast at -$35,425,803, and the highest MDWD earnings forecast at -$23,587,078.
In 2028, MDWD is forecast to generate -$15,889,970 in earnings, with the lowest earnings forecast at -$18,978,109 and the highest earnings forecast at -$13,284,676.